A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study

Clinical trial NCT00959647 · COMPLETED

Trial details

NCT number: NCT00959647
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Basal Cell Carcinoma Metastatic Colorectal Cancer

Start date: 2009-09-03
Primary completion: 2014-01-09
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.